The Maximus Testosterone Protocol (Enclomiphene) is based on extensive scientific research and clinical practice that has validated our approach. In fact, a recent review by top experts concluded that our therapy should “become the primary medication for men with secondary hypogonadism (low T) who wish to preserve spermatogenesis (fertility)… and is “a very promising drug for patients with secondary hypogonadism and who are concerned about the negative effects of exogenous testosterone (TRT).” Read more about how we increase testosterone levels by an average of ~2X at https://www.maximustribe.com/testosterone